Efficacy Study of Vx001 Vaccine in NSCLC Patients

Clinical trial NCT01935154 · COMPLETED

Trial details

NCT number: NCT01935154
Sponsor: Vaxon Biotech
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer Metastatic

Start date: 2012-08-01
Primary completion: 2017-01-01
Enrollment: 221

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.